Salvianolic Acid A Demonstrates Cardioprotective Effects in Rat Hearts and Cardiomyocytes After Ischemia/Reperfusion Injury

Male 0301 basic medicine Cardiotonic Agents L-Lactate Dehydrogenase Caspase 3 Cell Survival Myocardium Myocardial Infarction Apoptosis Heart In Vitro Techniques Myocardial Contraction Perfusion Necrosis 03 medical and health sciences Caffeic Acids Heart Rate Lactates Animals Myocytes, Cardiac Phosphorylation Cell Shape
DOI: 10.1097/fjc.0b013e31822de355 Publication Date: 2011-07-27T09:04:31Z
ABSTRACT
Salvianolic acid A (Sal A), the water-soluble component from the root of the Salvia miltiorrhiza plant, possesses antioxidant, antiproliferative, and antiplatelet properties. However, whether it plays a role in the protection against ischemia-reperfusion (I/R) injury in rat hearts has yet to be elucidated. In the present study, we tested cell viability, shortening amplitude, necrosis, apoptosis, and the expression levels of Akt, phosphorylated Akt, Bcl-2, Bax, and caspase-3 after 3-hour simulated ischemia and 2- or 6-hour simulated reperfusion in cardiomyocytes. We further observed the contractile function and infarct size in isolated hearts after they were subjected to global 30-minute ischemia and 120-minute reperfusion. Pretreatment with Sal A markedly increased cell viability and shortening amplitude while reducing evidence of necrosis and apoptosis in the cells. In addition, the expression of Bcl-2 was upregulated and Bax was downregulated, thereby increasing the Bcl-2/Bax ratio. Sal A inhibited the activation of caspase-3 as well. The results also showed that Sal A significantly increased phosphorylation of Akt and that this phosphorylation can be partially inhibited by phosphoinositide 3-kinase/Akt inhibitor. Furthermore, Sal A improved I/R-induced myocardial contractile function and reduced infarct size. In summary, our results showed that Sal A prevents I/R-induced myocardial damage by reducing necrosis and apoptosis in isolated rat hearts and cardiomyocytes.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (38)
CITATIONS (37)